# US 2016/0250353 A1 · Creped prebiotic tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250353 A1
- Document ID: US20160250353A1
- Status: Published application
- Kind: A1
- Application number: 14/766,087
- Filed: 2014-09-30
- Published: 2016-09-01
- Earliest claimed: 2014-09-30
- Assignees: Kimberly-Clark Worldwide, Inc.
- Applicants: Kimberly-Clark Worldwide, Inc.
- Inventors: Michael Andrew Zawadzki; Jeffrey Janne Johnson; David William Koenig; Amy Lynn Vanden Heuvel; David Andrew Moline; Rebecca Ann Vongsa; Cathleen Mae Uttecht; Donald Eugene Waldroup
- Web page: https://patentgrep.com/patent/US20160250353A1

## CPC

- A61K 47/6953: {the form being a fibre, a textile, a slab or a sheet}
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/733: Fructosans, e.g. inulin
- A61K 47/595: {Polyamides, e.g. nylon (polyamino acids A61K47/62)}
- A61L 15/42: Use of materials characterised by their function or physical properties (liquid bandages A61L26/00)
- A61L 15/44: Medicaments
- B31F 1/12: Crêping
- B31F 1/126: {including making of the paper to be crêped}
- D21H 21/146: {Crêping adhesives}
- D21H 27/00: Special paper not otherwise provided for, e.g. made by multi-step processes
- D21H 27/002: {Tissue paper; Absorbent paper (D21H21/22, D21H27/02, D21H27/20 take precedence; toilet paper A47K10/00; absorbent pads for physiological fluids A61L15/16; making on paper-making machines D21F11/00)}
- A61F 2/04: Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts (A61F2/18, A61F2/20 take precedence; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95)
- A61F 2002/045: {Stomach, intestines}
- A61L 2300/232: Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B31F: MECHANICAL WORKING OR DEFORMATION OF PAPER, CARDBOARD OR MATERIAL WORKED IN A MANNER ANALOGOUS TO PAPER (making layered products not composed wholly of paper or cardboard B32B)
- D21H: PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The invention relates to creped prebiotic tissue products. The tissue products comprise prebiotics in sufficiently high amounts to have a prebiotic effect in use, without negatively affecting tissue product properties, such as tensile strength, stiffness or softness. Thus, in certain embodiments the present invention provides soft, durable creped prebiotic tissue products that are able to improve the growth of healthy bacteria such as Bifidobacterium spp. or Lactobacillus spp. without promoting growth of enteropathogenic bacteria. The tissue products provide these benefits yet have a GMT greater than about 500, a Stiffness Index less than about 20 and a TS7 value less than about 10.

## Claims

### Claim 1

A creped tissue web comprising greater than about 2 mg prebiotic per square meter of web surface area (mg/m2), the web having a basis weight greater than about 10 grams per square meter (gsm) and a bulk greater than about 3 cubic centimeters per gram (cc/g).

### Claim 2 (depends on 1)

The creped tissue web of claim 1 having a TS7 value less than about 10.

### Claim 3 (depends on 1)

The creped tissue web of claim 1 wherein the web has a basis weight from about 15 to about 30 gsm.

### Claim 4 (depends on 1)

The creped tissue web of claim 1 wherein the web has a geometric mean tensile (GMT) strength greater than about 500 g/3″.

### Claim 5 (depends on 1)

The creped tissue web of claim 1 further comprising an α-hydroxy acid.

### Claim 6 (depends on 1)

The creped tissue web of claim 1 wherein the tissue web comprises from about 2 to about 1,000 mg/m2 prebiotic selected from the group consisting of inulin, fructo-oligosaccharide (FOS), lactulose, galacto-oligosaccharide (GOS), raffinose, stachyose, isomalto-oligosaccharide, and xylo-oligosaccharide.

### Claim 7 (depends on 5)

The creped tissue web of claim 5 wherein the weight ratio of α-hydroxy acid to prebiotic agent is from about 1:1 to about 1:1,000.

### Claim 8 (depends on 5)

The creped tissue web of claim 5 wherein the α-hydroxy acid is selected from the group consisting of citric acid, lactic acid, methyllactic acid, phenyllactic acid, malic acid, mandelic acid, glycolic acid, tartronic acid, tartaric acid and gluconic acid.

### Claim 9 (depends on 1)

The creped tissue web of claim 1 having a TS7 value from about 8.0 to about 10.

### Claim 10 (depends on 1)

The creped tissue web of claim 1 having a fine creped structure, measured as % COV at a wavelength from 200 to 390 μm, from about 20 to about 25.

### Claim 11 (depends on 1)

A multi-ply creped tissue product comprising the creped tissue web of claim 1.

### Claim 12 (depends on 11)

The multi-ply creped tissue product of claim 11 wherein the tissue product has a basis weight from about 25 to about 40 gsm.

### Claim 13 (depends on 11)

The multi-ply creped tissue product of claim 11 wherein the product has a GMT from about 500 g/3″ to about 1,000 g/3″.

### Claim 14 (depends on 11)

The multi-ply creped tissue product of claim 11 wherein the product has a Stiffness Index from about 15 to about 20.

### Claim 15

A method of manufacturing a prebiotic creped tissue web comprising the steps of dispersing cellulosic fibers to form a fiber slurry, forming a wet tissue web, partially dewatering the wet tissue web, applying a creping composition comprising a prebiotic to a creping cylinder, pressing the partially dewatered tissue web to the creping cylinder, drying the tissue web and creping the dried tissue web from the creping cylinder.

### Claim 16 (depends on 15)

The method of claim 15 wherein the creping composition further comprises an adhesive agent selected from the group consisting of polyvinyl alcohol, ethylene/vinyl acetate copolymer, animal glue, polyamidoamine-epichlorohydrin resins (PAE resins) and polyvinyl acetate and optionally a release agent selected from the group consisting of aliphatic polyols or oligomers thereof having a number average molecular weight of less than 600, polyalkanolamines, aromatic sulfonamides and pyrrolidone.

### Claim 17 (depends on 15)

The method of claim 15 wherein the creping composition further comprises water and the composition comprises from about 1 to about 100 mg/L prebiotic.

### Claim 18 (depends on 15)

The method of claim 15 wherein the creping composition is applied to the creping cylinder at an add-on level from about 10 to about 2,000 mg per square meter of creping cylinder surface area.

### Claim 19 (depends on 15)

The method of claim 15 wherein the creping composition further comprises an α-hydroxy acid selected from the group consisting of citric acid, lactic acid, methyllactic acid, phenyllactic acid, malic acid, mandelic acid, glycolic acid, tartronic acid, tartaric acid and gluconic acid.

### Claim 20 (depends on 19)

The method of claim 19 wherein the weight ratio of α-hydroxy acid to prebiotic agent is from about 1:100 to about 1:500.
